These innovative companies are developing revolutionary blood tests that can detect cancer earlier and more accurately than ever before. Carefully selected by healthcare investment experts, this collection represents the forefront of non-invasive diagnostics poised to transform the multi-billion dollar oncology market.
These companies are developing technology that could revolutionize how we detect and monitor cancer. Early detection means better outcomes, creating both healthcare impact and significant profit potential.
Imagine detecting cancer with just a routine blood draw. This simplicity is driving rapid adoption that could capture billions from traditional diagnostic methods and create entirely new screening markets.
FDA approvals and insurance coverage are accelerating for these technologies. Each new approval can trigger significant stock movements as companies transition from research phase to commercial revenue growth.
We've identified companies pioneering blood-based cancer testing that could fundamentally transform oncology care. These technologies enable detection of cancer's genetic signatures from simple blood draws, potentially shifting treatment from late-stage intervention to early detection when outcomes are better and costs are lower.
This collection offers growth potential by targeting the expanding medical diagnostics sector. Companies range from established market leaders to promising biotech innovators. The sector is gaining momentum as regulatory approvals increase and insurance companies expand coverage, validating these technologies.
These companies were handpicked based on their leadership in developing non-invasive cancer diagnostics, commercial success of existing products, or promising late-stage clinical pipelines. Each represents a strategic position in the evolution toward blood-based testing that could redefine cancer screening and monitoring.
Summary of the basket's total market capitalisation and concentration by large-cap constituents.
GH: $8.42B
EXAS: $12.00B
VCYT: $2.84B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Home Depot's recent earnings beat highlights consistent consumer spending on smaller household repair and maintenance projects. This ongoing trend presents promising opportunities for various home improvement retailers and building material suppliers.
BHP Group recently posted a massive earnings beat driven by record copper profitability, allowing the miner to raise its dividend to a four-year high. This performance highlights a structural shift toward electrification metals, creating opportunities for industrial equipment suppliers and competing copper producers.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+82.56%
On average, analysts expect assets in this group to grow 82.56% over the next year.
13 of 14 assets in this group are rated Buy by professional analysts.
